Mark Anthony McCamish
CIK 1390798 · President and CEO · last filed 2026-02-12
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Loading insider history…
Disclosed Exposure
$275.5K
Companies
6
Total Filings
36
Lifetime Open-Market Net
-$5.36M
Holdings By Company
Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| AVADEL PHARMACEUTICALS PLC (AVDL) Delisted | Director | 0 | $21.64 | $0 | -$537.1K | 13 | 2026-02-12 |
| RFL | Director | 60,241 | $2.24 | $134.9K | $0 | 3 | 2024-01-08 |
| Vincerx Pharma, Inc. (VINCW) Delisted | Director | — | $1.61 | — | $0 | 1 | 2020-12-28 |
| Forty Seven, Inc. (FTSV) Delisted | President and CEO | 0 | — | — | -$4.82M | 12 | 2020-04-07 |
| FACT | Sr. VP & Chief Medical Officer | 13,200 | $10.65 | $140.6K | $0 | 3 | 2009-04-06 |
| PDL BIOPHARMA, INC. (PDLI) Delisted | SVP & CMO | 14,924 | — | — | $0 | 4 | 2008-12-19 |
Recent Filings · Page 3 of 4
36 filingsForm 4 transactions across all companies, newest first.
| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2019-06-27 | Forty Seven, Inc. (FTSV) Delisted | Mixed | — | -$50.4K | EDGAR |
| 2019-06-24 | Forty Seven, Inc. (FTSV) Delisted | Mixed | — | -$51.1K | EDGAR |
| 2019-05-22 | Forty Seven, Inc. (FTSV) Delisted | Mixed | — | -$119.2K | EDGAR |
| 2019-04-22 | Forty Seven, Inc. (FTSV) Delisted | Mixed | — | -$218.5K | EDGAR |
| 2019-03-21 | Forty Seven, Inc. (FTSV) Delisted | Mixed | — | -$218.8K | EDGAR |
| 2019-02-21 | Forty Seven, Inc. (FTSV) Delisted | Mixed | — | -$166.8K | EDGAR |
| 2019-01-29 | Forty Seven, Inc. (FTSV) Delisted | Exer (M) | +51,687 | $252.4K | EDGAR |
| 2019-01-23 | Forty Seven, Inc. (FTSV) Delisted | Mixed | — | -$194.2K | EDGAR |
| 2018-12-28 | Forty Seven, Inc. (FTSV) Delisted | Mixed | — | -$132.2K | EDGAR |
| 2009-04-06 | FACT | Grant (A) | — | $0 | EDGAR |
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.